Orhue Odaro

Orhue Odaro practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Orhue Odaro's NPI, 1972999407, was assigned on April 10, 2015. Orhue Odaro graduated from Baylor College Of Medicine in 2015. Orhue Odaro holds Texas license BP10052926.

Orhue Odaro's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Orhue Odaro's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service. Dmand AI also links Orhue Odaro to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Orhue Odaro practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Orhue Odaro's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Orhue Odaro is board certified in internal medicine by the American Board of Internal Medicine. Orhue Odaro is licensed in Texas.

Dmand AI lists acute respiratory failure, anemia, bile duct problems, cirrhosis, gastrointestinal infection, gastrointestinal inflammation, heart attack and hypertension among the conditions Orhue Odaro treats.

CMS data shows 451 Medicare services from Orhue Odaro across 5 procedure codes in 2024, for 156 Medicare patients. Medicare paid $41,132 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 156 Medicare patients who saw Orhue Odaro in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Orhue Odaro's median patient age at 70, with 54% women.

In 2024, Orhue Odaro wrote 197 Medicare Part D claims for 71 patients. 88% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $7,073 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Orhue Odaro for performance year 2024, reported as part of a group. Orhue Odaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Orhue Odaro, published from 2022 to 2025. Orhue Odaro's most frequent co-authors are Kodwo Bosemefi Dickson, MD, Josiah K. Halm, MD and Kwame Koom-Dadzie, MD.

CMS Open Payments shows 1 general payment to Orhue Odaro from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $10.

Dmand AI lists 1 award for Orhue Odaro, most recently Excellence in Education Faculty Honoree for Education and Mentoring Advancement in 2022.

Orhue Odaro graduated from Baylor College Of Medicine in 2015.

Orhue Odaro is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.